Quorum Sensing and Quorum Quenching in Pseudomonas aeruginosa and Staphylococcus aureus Infections: Therapeutic Potential, Limitations and Clinical Challenges
Antibiotics · 29.04.2026 · 15 (5) · 447
DOI: 10.3390/antibiotics15050447 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 29.04.2026. Verfasst von Emilia Nowak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Billennium Spółka Akcyjna, Tadeusza Czackiego 15/17, 00-043 Warsaw, Poland. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Antimicrobial resistance (AMR) represents a major global health threat, largely driven by antibiotic overuse and the protective role of bacterial biofilms. Quorum sensing (QS), a bacterial communication system regulating virulence and biofilm formation, has emerged as a promising therapeutic target. Quorum quenching (QQ), which disrupts QS without directly inhibiting bacterial growth, is considered a potential anti-virulence strategy that may reduce selective pressure for resistance. This review critically evaluates recent advances in QQ research, focusing on its clinical applicability, limitations, and risks. We analyzed studies from the last five years involving natural compounds, synthetic molecules, nanoparticles (NPs), and combination therapies targeting key pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus in models of lung diseases, mainly cystic fibrosis, chronic wounds, burns, and implant-associated infections. While numerous compounds demonstrate significant in vitro anti-biofilm and anti-virulence activity, major challenges remain, including limited in vivo validation, pharmacokinetic constraints, toxicity concerns, microbiome disruption, and the potential development of tolerance or functional resistance. Although QQ offers a promising adjunctive approach to conventional antibiotics, its long-term clinical feasibility requires comprehensive evaluation of evolutionary dynamics, host–microbe interactions, and safety profiles.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Billennium Spółka Akcyjna, Tadeusza Czackiego 15/17, 00-043 Warsaw, Poland.
- Faculty of Medicine, Wroclaw Medical University, 50-376 Wroclaw, Poland.
- Department of Pharmacognosy with Medicinal Plants Garden, Lublin Medical University, 20-093 Lublin, Poland.
- German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC), Department of Infectious Diseases, Medical Microbiology and Hygiene, Medical Faculty Heidelberg University, Im Neuenheimer Fel…
- Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, Tytusa Chalubinskiego 4, 50-376 Wroclaw, Poland.
ORCID-Profile: Emilia Nowak, Matylda Korgiel, Karolina Pawłuszkiewicz, Jarosław Widelski, Emil Paluch
Zitieren
APA
Nowak, E., Korgiel, M., Pawłuszkiewicz, K., Widelski, J., Cheaib, B., & Paluch, E. (2026). Quorum Sensing and Quorum Quenching in Pseudomonas aeruginosa and Staphylococcus aureus Infections: Therapeutic Potential, Limitations and Clinical Challenges. Antibiotics, 15(5), 447. https://doi.org/10.3390/antibiotics15050447
Vancouver
Nowak E, Korgiel M, Pawłuszkiewicz K, Widelski J, Cheaib B, Paluch E. Quorum Sensing and Quorum Quenching in Pseudomonas aeruginosa and Staphylococcus aureus Infections: Therapeutic Potential, Limitations and Clinical Challenges. Antibiotics. 2026;15(5):447. doi:10.3390/antibiotics15050447
BibTeX
@article{Nowak2026,
author = {Nowak, Emilia and Korgiel, Matylda and Pawłuszkiewicz, Karolina and Widelski, Jarosław and Cheaib, Bachar and Paluch, Emil},
title = {Quorum Sensing and Quorum Quenching in Pseudomonas aeruginosa and Staphylococcus aureus Infections: Therapeutic Potential, Limitations and Clinical Challenges},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {5},
pages = {447},
doi = {10.3390/antibiotics15050447}
}
EUVIMED